Home › Meningioma › Michigan › Detroit
Meningioma clinical trials in Detroit, MI
4 studies for Meningioma are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- Henry Ford Hospital, Detroit
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Henry Ford Health System, Detroit
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Columbus, OH6 studies
- Boston, MA6 studies
- Jacksonville, FL5 studies
- San Francisco, CA5 studies
- Atlanta, GA5 studies
- San Diego, CA5 studies
- Phoenix, AZ4 studies
- Houston, TX4 studies
- Arlington, VA4 studies
- Durham, NC3 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.